Tuesday, September 29, 2015

Drug for early breast cancer licensed

… experts. Pertuzumab (Perjeta) fights HER2-positive breast cancer and its new licence means … was already licensed for advanced breast cancer. According to manufacturer Roche, the … 15% of women with early-stage breast cancer have HER2-positive tumours. These tumours …

No comments:

Post a Comment